Back to Woodline Partners LP Woodline Partners LP

IMVTIMVT

Showing 8 of 26 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in Immunovant, Inc.

Yes. Woodline Partners holds 1,975,869 shares of IMVT (Immunovant), worth $76.1M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Woodline Partners has held IMVT since Q2 2022, across 17 quarterly 13F filings. IMVT is 0.2% of Woodline Partners' reported 13F portfolio.

Current Value

$76.1M

Current Shares

2M

Total Value Change

+$35.8M

Total Shares Change

+560,892

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
2M
0.0%
$76.1M0.2%$38.53
0
2026-Q1
Unchanged
2M
0.0%
$49.1M0.2%$26.71
0
2025-Q4
Increased
2M
+31.8%
$50.2M0.2%$25.42
45
2025-Q3
Unchanged
1.5M
0.0%
$24.2M0.1%$16.12
0
2025-Q2
Increased
1.5M
+0.1%
$24M0.1%$16.00
34
2025-Q1
Increased
1.5M
+133.1%
$25.6M0.2%$17.09
55
2024-Q4
Decreased
642,726
-54.6%
$15.9M0.1%$24.77
0
2024-Q3
Decreased
1.4M
-22.4%
$40.3M0.3%$28.02
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used